Livzon Pharmaceutical details extensive A-share repurchase activity

Livzon Pharmaceutical Group Inc. reported its Next Day Disclosure Return on November 6, 2025, revealing significant A-share repurchase activities. As of the closing balance on November 6, 2025, the total number of issued H-shares remained unchanged at 299,807,117.

The company undertook numerous A-share repurchases on the Shenzhen Stock Exchange, with the latest activity on November 6, 2025, involving 163,414 A-shares at a volume-weighted average repurchase price of RMB36.705 per share (highest RMB36.77, lowest RMB36.61). This specific repurchase amounted to RMB5,997,099.8. Prior to this, on November 5, 2025, 164,200 A-shares were repurchased at RMB36.54 per share.

The detailed breakdown in the disclosure shows 89 separate A-share repurchase events between December 25, 2024, and November 6, 2025. These repurchases varied in volume, from a low of 1,700 shares on August 1, 2025, to a high of 561,400 shares on January 14, 2025. Repurchase prices ranged from RMB33.9 to RMB41.99 per share, reflecting market fluctuations over the period. These repurchased shares are yet to be cancelled.